U.S. PHYSICAL THERAPY INC (USPH) Fundamental Analysis & Valuation

NYSE:USPH • US90337L1089

Current stock price

74.75 USD
+0.33 (+0.44%)
At close:
74.75 USD
0 (0%)
After Hours:

This USPH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. USPH Profitability Analysis

1.1 Basic Checks

  • USPH had positive earnings in the past year.
  • In the past year USPH had a positive cash flow from operations.
  • In the past 5 years USPH has always been profitable.
  • In the past 5 years USPH always reported a positive cash flow from operatings.
USPH Yearly Net Income VS EBIT VS OCF VS FCFUSPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

1.2 Ratios

  • USPH has a Return On Assets (1.79%) which is comparable to the rest of the industry.
  • USPH's Return On Equity of 4.53% is in line compared to the rest of the industry. USPH outperforms 59.00% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 6.13%, USPH is in the better half of the industry, outperforming 62.00% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for USPH is below the industry average of 8.74%.
  • The 3 year average ROIC (5.65%) for USPH is below the current ROIC(6.13%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.79%
ROE 4.53%
ROIC 6.13%
ROA(3y)2%
ROA(5y)2.71%
ROE(3y)4.67%
ROE(5y)6.76%
ROIC(3y)5.65%
ROIC(5y)6.27%
USPH Yearly ROA, ROE, ROICUSPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • USPH's Profit Margin of 2.76% is fine compared to the rest of the industry. USPH outperforms 66.00% of its industry peers.
  • USPH's Profit Margin has declined in the last couple of years.
  • USPH has a Operating Margin of 11.13%. This is amongst the best in the industry. USPH outperforms 81.00% of its industry peers.
  • USPH's Operating Margin has declined in the last couple of years.
  • USPH has a worse Gross Margin (19.20%) than 60.00% of its industry peers.
  • USPH's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.13%
PM (TTM) 2.76%
GM 19.2%
OM growth 3Y-2.24%
OM growth 5Y-3.51%
PM growth 3Y-19.51%
PM growth 5Y-18.15%
GM growth 3Y-1.76%
GM growth 5Y-3.76%
USPH Yearly Profit, Operating, Gross MarginsUSPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. USPH Health Analysis

2.1 Basic Checks

  • USPH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for USPH remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, USPH has more shares outstanding
  • The debt/assets ratio for USPH is higher compared to a year ago.
USPH Yearly Shares OutstandingUSPH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
USPH Yearly Total Debt VS Total AssetsUSPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • USPH has an Altman-Z score of 2.08. This is not the best score and indicates that USPH is in the grey zone with still only limited risk for bankruptcy at the moment.
  • USPH has a Altman-Z score of 2.08. This is comparable to the rest of the industry: USPH outperforms 54.00% of its industry peers.
  • The Debt to FCF ratio of USPH is 2.66, which is a good value as it means it would take USPH, 2.66 years of fcf income to pay off all of its debts.
  • USPH has a Debt to FCF ratio of 2.66. This is in the better half of the industry: USPH outperforms 72.00% of its industry peers.
  • A Debt/Equity ratio of 0.32 indicates that USPH is not too dependend on debt financing.
  • USPH has a better Debt to Equity ratio (0.32) than 67.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 2.66
Altman-Z 2.08
ROIC/WACC0.72
WACC8.52%
USPH Yearly LT Debt VS Equity VS FCFUSPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 1.01 indicates that USPH should not have too much problems paying its short term obligations.
  • USPH's Current ratio of 1.01 is on the low side compared to the rest of the industry. USPH is outperformed by 73.00% of its industry peers.
  • A Quick Ratio of 1.01 indicates that USPH should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.01, USPH is doing worse than 66.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.01
Quick Ratio 1.01
USPH Yearly Current Assets VS Current LiabilitesUSPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. USPH Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.55% over the past year.
  • Measured over the past years, USPH shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.67% on average per year.
  • USPH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.33%.
  • The Revenue has been growing by 13.05% on average over the past years. This is quite good.
EPS 1Y (TTM)1.55%
EPS 3Y-1.12%
EPS 5Y-1.67%
EPS Q2Q%3.08%
Revenue 1Y (TTM)16.33%
Revenue growth 3Y12.19%
Revenue growth 5Y13.05%
Sales Q2Q%12.35%

3.2 Future

  • Based on estimates for the next years, USPH will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.74% on average per year.
  • Based on estimates for the next years, USPH will show a quite strong growth in Revenue. The Revenue will grow by 8.13% on average per year.
EPS Next Y18.55%
EPS Next 2Y15.81%
EPS Next 3Y14.74%
EPS Next 5YN/A
Revenue Next Year7.58%
Revenue Next 2Y7.02%
Revenue Next 3Y8.13%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
USPH Yearly Revenue VS EstimatesUSPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
USPH Yearly EPS VS EstimatesUSPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

3

4. USPH Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 28.53, which means the current valuation is very expensive for USPH.
  • USPH's Price/Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 24.89, USPH is valued at the same level.
  • With a Price/Forward Earnings ratio of 24.07, USPH is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of USPH is on the same level as its industry peers.
  • When comparing the Price/Forward Earnings ratio of USPH to the average of the S&P500 Index (22.19), we can say USPH is valued inline with the index average.
Industry RankSector Rank
PE 28.53
Fwd PE 24.07
USPH Price Earnings VS Forward Price EarningsUSPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, USPH is valued a bit cheaper than the industry average as 66.00% of the companies are valued more expensively.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as USPH.
Industry RankSector Rank
P/FCF 18.53
EV/EBITDA 11.5
USPH Per share dataUSPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • USPH's earnings are expected to grow with 14.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.54
PEG (5Y)N/A
EPS Next 2Y15.81%
EPS Next 3Y14.74%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. USPH Dividend Analysis

5.1 Amount

  • USPH has a Yearly Dividend Yield of 2.46%. Purely for dividend investing, there may be better candidates out there.
  • USPH's Dividend Yield is rather good when compared to the industry average which is at 0.50. USPH pays more dividend than 95.00% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, USPH pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.46%

5.2 History

  • The dividend of USPH is nicely growing with an annual growth rate of 41.45%!
  • USPH has been paying a dividend for at least 10 years, so it has a reliable track record.
  • USPH has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)41.45%
Div Incr Years4
Div Non Decr Years4
USPH Yearly Dividends per shareUSPH Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • USPH pays out 126.84% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of USPH is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP126.84%
EPS Next 2Y15.81%
EPS Next 3Y14.74%
USPH Yearly Income VS Free CF VS DividendUSPH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
USPH Dividend Payout.USPH Dividend Payout, showing the Payout Ratio.USPH Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

USPH Fundamentals: All Metrics, Ratios and Statistics

U.S. PHYSICAL THERAPY INC

NYSE:USPH (3/27/2026, 8:04:00 PM)

After market: 74.75 0 (0%)

74.75

+0.33 (+0.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners109.33%
Inst Owner Change-1.69%
Ins Owners2.09%
Ins Owner Change10.22%
Market Cap1.13B
Revenue(TTM)780.99M
Net Income(TTM)21.57M
Analysts84.62
Price Target106.08 (41.91%)
Short Float %6.91%
Short Ratio4.68
Dividend
Industry RankSector Rank
Dividend Yield 2.46%
Yearly Dividend1.81
Dividend Growth(5Y)41.45%
DP126.84%
Div Incr Years4
Div Non Decr Years4
Ex-Date03-13
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2.45%
Min EPS beat(2)-3.42%
Max EPS beat(2)-1.47%
EPS beat(4)2
Avg EPS beat(4)3.9%
Min EPS beat(4)-3.42%
Max EPS beat(4)11.07%
EPS beat(8)2
Avg EPS beat(8)-2%
EPS beat(12)4
Avg EPS beat(12)-0.8%
EPS beat(16)6
Avg EPS beat(16)-0.92%
Revenue beat(2)0
Avg Revenue beat(2)-0.6%
Min Revenue beat(2)-0.83%
Max Revenue beat(2)-0.36%
Revenue beat(4)2
Avg Revenue beat(4)0.63%
Min Revenue beat(4)-0.83%
Max Revenue beat(4)2.04%
Revenue beat(8)5
Avg Revenue beat(8)0.55%
Revenue beat(12)7
Avg Revenue beat(12)0.5%
Revenue beat(16)8
Avg Revenue beat(16)-0.01%
PT rev (1m)-0.19%
PT rev (3m)0.39%
EPS NQ rev (1m)-8.66%
EPS NQ rev (3m)-8.66%
EPS NY rev (1m)1.95%
EPS NY rev (3m)1.95%
Revenue NQ rev (1m)1.77%
Revenue NQ rev (3m)1.77%
Revenue NY rev (1m)1.18%
Revenue NY rev (3m)1.18%
Valuation
Industry RankSector Rank
PE 28.53
Fwd PE 24.07
P/S 1.45
P/FCF 18.53
P/OCF 15.06
P/B 2.37
P/tB N/A
EV/EBITDA 11.5
EPS(TTM)2.62
EY3.51%
EPS(NY)3.11
Fwd EY4.16%
FCF(TTM)4.03
FCFY5.4%
OCF(TTM)4.96
OCFY6.64%
SpS51.65
BVpS31.51
TBVpS-25.72
PEG (NY)1.54
PEG (5Y)N/A
Graham Number43.1
Profitability
Industry RankSector Rank
ROA 1.79%
ROE 4.53%
ROCE 8.16%
ROIC 6.13%
ROICexc 6.35%
ROICexgc 39.8%
OM 11.13%
PM (TTM) 2.76%
GM 19.2%
FCFM 7.81%
ROA(3y)2%
ROA(5y)2.71%
ROE(3y)4.67%
ROE(5y)6.76%
ROIC(3y)5.65%
ROIC(5y)6.27%
ROICexc(3y)6.19%
ROICexc(5y)6.72%
ROICexgc(3y)38.13%
ROICexgc(5y)39.19%
ROCE(3y)7.52%
ROCE(5y)8.34%
ROICexgc growth 3Y3.57%
ROICexgc growth 5Y-9.06%
ROICexc growth 3Y-1.7%
ROICexc growth 5Y-6.83%
OM growth 3Y-2.24%
OM growth 5Y-3.51%
PM growth 3Y-19.51%
PM growth 5Y-18.15%
GM growth 3Y-1.76%
GM growth 5Y-3.76%
F-Score6
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 2.66
Debt/EBITDA 1.4
Cap/Depr 62.84%
Cap/Sales 1.8%
Interest Coverage 9.22
Cash Conversion 68.65%
Profit Quality 282.71%
Current Ratio 1.01
Quick Ratio 1.01
Altman-Z 2.08
F-Score6
WACC8.52%
ROIC/WACC0.72
Cap/Depr(3y)57.08%
Cap/Depr(5y)59.59%
Cap/Sales(3y)1.57%
Cap/Sales(5y)1.57%
Profit Quality(3y)306.85%
Profit Quality(5y)262.3%
High Growth Momentum
Growth
EPS 1Y (TTM)1.55%
EPS 3Y-1.12%
EPS 5Y-1.67%
EPS Q2Q%3.08%
EPS Next Y18.55%
EPS Next 2Y15.81%
EPS Next 3Y14.74%
EPS Next 5YN/A
Revenue 1Y (TTM)16.33%
Revenue growth 3Y12.19%
Revenue growth 5Y13.05%
Sales Q2Q%12.35%
Revenue Next Year7.58%
Revenue Next 2Y7.02%
Revenue Next 3Y8.13%
Revenue Next 5YN/A
EBIT growth 1Y24.46%
EBIT growth 3Y9.68%
EBIT growth 5Y9.08%
EBIT Next Year22.39%
EBIT Next 3Y15.15%
EBIT Next 5YN/A
FCF growth 1Y-7.25%
FCF growth 3Y6.64%
FCF growth 5Y-7.97%
OCF growth 1Y0.16%
OCF growth 3Y8.64%
OCF growth 5Y-5.58%

U.S. PHYSICAL THERAPY INC / USPH Fundamental Analysis FAQ

What is the ChartMill fundamental rating of U.S. PHYSICAL THERAPY INC (USPH) stock?

ChartMill assigns a fundamental rating of 4 / 10 to USPH.


What is the valuation status for USPH stock?

ChartMill assigns a valuation rating of 3 / 10 to U.S. PHYSICAL THERAPY INC (USPH). This can be considered as Overvalued.


What is the profitability of USPH stock?

U.S. PHYSICAL THERAPY INC (USPH) has a profitability rating of 5 / 10.


What are the PE and PB ratios of U.S. PHYSICAL THERAPY INC (USPH) stock?

The Price/Earnings (PE) ratio for U.S. PHYSICAL THERAPY INC (USPH) is 28.53 and the Price/Book (PB) ratio is 2.37.


Is the dividend of U.S. PHYSICAL THERAPY INC sustainable?

The dividend rating of U.S. PHYSICAL THERAPY INC (USPH) is 5 / 10 and the dividend payout ratio is 126.84%.